康聖環球 (9960.HK)

1.550 -0.010 (-0.64%) 收市：04:08PM HKT

康聖環球

Biolake D2-1
666 Gaoxin Road East lake Hi-Tech Zone
Wuhan
China
86 40 0736 1666
https://www.kindstar.com.cn/en/

版塊: Healthcare
行業: Diagnostics & Research
全職員工: 3,125

高階主管

名稱	頭銜	支付	行使價	出生年份
Dr. Shiang Huang	Founder, Executive Chairman, CEO & Chief Medical Officer	951.67k	無	1959
Mr. Zanbing Tu M.B.A.	Co-Founder, Executive Director & COO	963.55k	無	1972
Ms. Haijie Chai	Executive Director, CFO & Joint Company Secretary	660.01k	無	1979
Ms. Mei Yi Lee ACIS, ACS, FCIS, FCS	Joint Company Secretary	無	無	1968

截止 2022年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 HKD。

描述

Kindstar Globalgene Technology, Inc., together with its subsidiaries, provides clinical testing services in China. The company offers its esoteric testing services for hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology diseases. It also provides testing services for the early warning, prevention, diagnosis, selection of therapeutic schedules, and evaluation for curative effect of specialized diseases. The company's lab platforms comprise flow cytometry, cytogenetic, medical genomics, molecular biology, hematopathology, mass spectrum, pathology, clinical immunology, microbiology, and scientific research testing laboratories. Kindstar Globalgene Technology, Inc. was founded in 2003 and is headquartered in Wuhan, China.

公司管治

截至 無 止，康聖環球 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。